Andmed seisuga: 10.08.2020 10:55 (GMT+3)

InMedica 2Y 5.5% bond (20.05.2020)

Vilnius | First North võlakirjanimekiri

INMB055021FA  |  ISIN LT0000404246

Kauple

InMedica

InMedica

Name: UAB "InMedica" 
Core business: private healthcare services
Date of registration: 18 March 2004 
Auditor: UAB „Persense Audit“
Date of bond listing (First North): 9 March 2020 
Market: Nasdaq Vilnius

Management Board
Nerijus Drobavičius (Chairman), Rokas Grajauskas, Laura Penikienė, Ashwin Roy

Background Information
InMedica is a network of healthcare clinics which provide diagnostic and ambulatory care, surgery, dentistry and other medical services. Its healthcare professionals fully focus on each patient and their health at the group’s current 16 family medical centers, 3 broad profile clinics and 1 specialised cardio clinic in Lithuania. InMedica’s largest shareholder is the INVL Baltic Sea Growth Fund, whose main investor is the European Investment Fund – a part of the European Investment Bank. INVL Baltic Sea Growth Fund, the largest private equity investment fund for the Baltic region, is of a total €165mn size. In January 2019, the INVL Baltic Sea Growth Fund acquired a stake in InMedica” from the Baltcap private equity fund, which invested in the company in 2012.

Contact Details 
Address: L.Asanavičiūtės g. 20-201, Vilnius                     
Telephone/Fax: +370 5 265 1852 
E–mail: info@inmedica.lt
Contact person: Laura Penikienė (CEO), +370 5 265 1852

Dokumendid

Dokumendid

2020
Märts

Offer Document lt, 2 MB

Kaubeldavad väärtpaberid

Aktsiad
Võlakirjad
Fondid

Turuinfo

Statistika
Kauplemine
Indeksid
Oksjonid

Turureeglid

Reeglid ja hinnad
Järelevalve

Alusta siit

Ettevõttele
Investorile
Liikmetele
First North turu nõustajatele

Uudised

Nasdaqi uudised
Ettevõtete uudised
Kalender

Meist

Ettevõttest
Kontorid